So-Young International Inc.

NASDAQ:SY

Medical - Healthcare Information Services

Healthcare
$1.83 -5.83%

-$0.09 today

Market cap
$239.36M
Beta
1.98
P/E (TTM)
-5.0
EPS (TTM)
-$1.95
52W Low $1.00High $6.28

Volume 0.46M

Average 0.63M

SY Income Before Tax

Profit after all operating and non-operating items but before income tax.

So-Young International Inc.NASDAQ: SY

Income Before Tax · Q1 FY2026 · quarter ended Mar 2026

Income before tax remains negative

Q1 FY2026 income before tax was -CN¥50.65M, compared with -CN¥34.76M a year earlier. Trailing-twelve-month income before tax was -CN¥260.42M.

Context

  • Income before tax amounted to 16.2% of revenue in FY2025, down 23.9 pp from a year earlier.
  • Income before tax increased in 2 of the last 3 fiscal years.

What to watch

Whether quarterly income before tax holds near -CN¥50.65M or moves back toward the trailing-twelve-month quarterly average of -CN¥65.1M.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
-CN¥50.65M+55.2% QoQ
Last fiscal yearDec 2025
-CN¥239.4M+59.3% YoY
LTMMar 2026
-CN¥260.42M+56.6% YoY
Income Before Tax past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-45.7%——
1 year+59.3%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Income Before Tax history

CNY · from the income statement

Latest · FY2025
(239.4M) CNY
Year-over-year change
+59.3%

Income Before Tax vs competitors

How SY compares with its peers on the latest reported figures

  • Peers report in different currencies, so income before tax is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +56.6% is the 3rd highest of 11, against a peer median of -7.0%.
  • Income before tax amounts to 15.8% of revenue for SY, versus a peer median of 90.2%.
SY Competitors
Income Before Tax for SY and competitors
Company Period LTM YoY 3-year CAGR% of revenue
OMEROmeros CorporationLTM Mar 2026$86.08M USD+148.8%—870.1%
LXRXLexicon Pharmaceuticals, Inc.LTM Mar 2026-$26.09M USD+85.3%—37.5%
SLPSimulations Plus, Inc.LTM Feb 2026-$66.3M USD-877.2%—82.3%
VREXVarex Imaging CorporationLTM Apr 2026-$75.1M USD-552.4%—8.8%
SOPHSOPHiA GENETICS S.A.LTM Mar 2026-$79.67M USD-23.0%—98.1%
LABStandard BioTools Inc.LTM Mar 2026-$87.83M USD+19.8%—101.8%
SNDASonida Senior Living, Inc.LTM Mar 2026-$100.45M USD-133.2%—24.4%
ADCTADC Therapeutics S.A.LTM Mar 2026-$136.14M USD+9.0%—171.9%
CGEMCullinan Therapeutics, Inc.LTM Mar 2026-$221.04M USD-23.7%——
NMRANeumora Therapeutics, Inc. Common StockLTM Mar 2026-$222.34M USD+13.7%——
SYSo-Young International Inc.LTM Mar 2026-CN¥260.42M CNY+56.6%—15.8%
Peer median (excluding SY) —-7.0%—90.2%

Competitors are the stored peer set for SY. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

CNY
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue1.69B1.26B1.5B1.47B1.48B
Cost of Revenue327.89M393.29M544.34M567.59M774.04M
Gross Profit1.36B864.58M953.69M899.11M707.86M
Gross Margin80.6%68.7%63.7%61.3%47.8%
Research & Development286.57M235.09M203.52M165.03M133.31M
Selling, General & Admin1.04B732.3M811.22M818.57M833.76M
Operating Expenses1.4B967.39M1.01B1.52B967.07M
Depreciation & Amortization30.08M47.09M46.09M46.09M57.21M
EBITDA63.39M(39.99M)53.96M(38.39M)(182.19M)
EBITDA Margin3.7%-3.2%3.6%-2.6%-12.3%
Operating Income(32.57M)(102.81M)(61.05M)(624.49M)(259.21M)
Operating Margin-1.9%-8.2%-4.1%-42.6%-17.5%
Interest Income19.33M28.88M48.84M46.51M24.6M
Interest Expense00000
Other Income / Expenses16.17M15.73M68.92M36.41M19.8M
Income Before Tax(16.41M)(87.07M)7.87M(588.09M)(239.4M)
Pre-Tax Margin-1.0%-6.9%0.5%-40.1%-16.2%
Income Tax Expense21.23M(20.97M)(18.08M)(905K)(774.31K)
Net Income(8.37M)(65.55M)21.28M(589.53M)(235.7M)
Net Margin-0.5%-5.2%1.4%-40.2%-15.9%
EPS (Basic)(0.06)(0.48)0.16(4.40)(1.78)
EPS (Diluted)(0.06)(0.48)0.16(4.39)(1.78)
Weighted Avg Shares138.04M138.04M133.19M134.09M131.59M
Weighted Avg Shares (Diluted)138.04M138.04M131.91M134.16M131.59M

So-Young International Inc.

NASDAQ:SY

Intrinsic Alpha fair value

Locked

Current Price

$1.83

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.